Search Clinical Trials
583,492 trials
ID
Status
Phase
Title
Sponsor
NCT07573436
Loncastuximab Tesirine and Rituximab as First-line Therapy in Patients With Post-transplant Lymphoproliferative Disorder (PLUTO)ADC Therapeutics S.A.Not Yet RecruitingPhase 1
NCT07573436Not Yet Recruiting
Phase 1
Loncastuximab Tesirine and Rituximab as First-line Therapy in Patients With Post...ADC Therapeutics S.A.
NCT07573956
Trial Evaluating Hypo-fractionated Accelerated Versus Conventional Fractionated Adjuvant RT in Head & Neck MalignanciesAll India Institute of Medical SciencesRecruitingPhase 2
NCT07573956Recruiting
Phase 2
Trial Evaluating Hypo-fractionated Accelerated Versus Conventional Fractionated...All India Institute of Me...
NCT07573683
Additional Effect of Coherent Breathing With Aerobic Exercise on Cardiopulmonary Parameters and Quality of Life in Stage 1 Hypertensive IndividualsFoundation University IslamabadRecruitingNot Applicable
NCT07573683Recruiting
Not Applicable
Additional Effect of Coherent Breathing With Aerobic Exercise on Cardiopulmonary...Foundation University Isl...
NCT07574177
Effects of Timed Restricted Eating on Body Composition, Metabolism, and Cardiovascular HealthUniversity of South AlabamaNot Yet RecruitingNot Applicable
NCT07574177Not Yet Recruiting
Not Applicable
Effects of Timed Restricted Eating on Body Composition, Metabolism, and Cardiova...University of South Alaba...
NCT07572149
THE EFFECT OF FOOD SAFETY TRAINING ON EMPLOYEES' KNOWLEDGE, ATTITUDES, AND PRACTICES: A SOLOMON FOUR-GROUP EXPERIMENTKayseri UniversityCompletedNot Applicable
NCT07572149Completed
Not Applicable
THE EFFECT OF FOOD SAFETY TRAINING ON EMPLOYEES' KNOWLEDGE, ATTITUDES, AND PRACT...Kayseri University
NCT07572903
The Efficacy and Safety of Temporal Interference Stimulation on Motor Symptoms of Parkinson's DiseaseThe First Affiliated Hospital of Anhui Medical UniversityNot Yet RecruitingNot Applicable
NCT07572903Not Yet Recruiting
Not Applicable
The Efficacy and Safety of Temporal Interference Stimulation on Motor Symptoms o...The First Affiliated Hosp...
NCT07573670
A Phase 2 Study of Bcl-2 Inhibitor Combined With Azacitidine for Newly Diagnosed Mixed Phenotype Acute LeukemiaThe First Affiliated Hospital of Soochow UniversityNot Yet RecruitingPhase 2
NCT07573670Not Yet Recruiting
Phase 2
A Phase 2 Study of Bcl-2 Inhibitor Combined With Azacitidine for Newly Diagnosed...The First Affiliated Hosp...
NCT07573579
Dynamic Voltage Mapping to Personalise the Ventricular Tachycardia SubstrateLiverpool Heart and Chest Hospital NHS Foundation TrustNot Yet RecruitingNot Applicable
NCT07573579Not Yet Recruiting
Not Applicable
Dynamic Voltage Mapping to Personalise the Ventricular Tachycardia SubstrateLiverpool Heart and Chest...
NCT07573631
An Open-Label Extension Study to Evaluate the Long-term Safety and Efficacy of BMN 351 in Participants With Duchenne Muscular DystrophyBioMarin PharmaceuticalEnrolling By InvitationPhase 2
NCT07573631Enrolling By Invitation
Phase 2
An Open-Label Extension Study to Evaluate the Long-term Safety and Efficacy of B...BioMarin Pharmaceutical
NCT07574307
Kinesiotaping in Isolated Meniscus InjuriesBandırma Onyedi Eylül UniversityRecruitingNot Applicable
NCT07574307Recruiting
Not Applicable
Kinesiotaping in Isolated Meniscus InjuriesBandırma Onyedi Eylül Uni...
NCT07572123
Evaluating the Addition of Maintenance Immunotherapy Compared to the Usual Treatment of Chemotherapy and Autologous Stem Cell Transplant Alone for High-risk Patients With Relapsed or Refractory Hodgkin LymphomaNational Cancer Institute (NCI)Not Yet RecruitingPhase 2
NCT07572123Not Yet Recruiting
Phase 2
Evaluating the Addition of Maintenance Immunotherapy Compared to the Usual Treat...National Cancer Institute...
NCT07572175
Sotagliflozin as Prevention of Anthracycline-Related CardiotoxicityAmerican Heart AssociationNot Yet RecruitingPhase 2
NCT07572175Not Yet Recruiting
Phase 2
Sotagliflozin as Prevention of Anthracycline-Related CardiotoxicityAmerican Heart Associatio...
NCT07572864
Neoadjuvant ICI and Mitochondrial Vaccine for Resectable HNSCCWest China HospitalNot Yet RecruitingPhase 2
NCT07572864Not Yet Recruiting
Phase 2
Neoadjuvant ICI and Mitochondrial Vaccine for Resectable HNSCCWest China Hospital
NCT07573332
A Safety and Tolerability Study of CC- 97540 (BMS-086353) in Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica PatientsBristol-Myers SquibbNot Yet RecruitingPhase 1
NCT07573332Not Yet Recruiting
Phase 1
A Safety and Tolerability Study of CC- 97540 (BMS-086353) in Anti-Aquaporin 4 An...Bristol-Myers Squibb
NCT07573748
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospital of Huai'anNot Yet RecruitingNot Applicable
NCT07573748Not Yet Recruiting
Not Applicable
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospi...
NCT07574255
3D-US Construct on Volumetric Assessment of Lung Disease & Clinical ApplicationNational Taiwan University HospitalNot Yet Recruiting
NCT07574255Not Yet Recruiting
—
3D-US Construct on Volumetric Assessment of Lung Disease & Clinical ApplicationNational Taiwan Universit...
NCT07573722
Neck Exercises for Improving Pelvic Alignment and Low Back PainYuanpei University of Medical TechnologyCompletedNot Applicable
NCT07573722Completed
Not Applicable
Neck Exercises for Improving Pelvic Alignment and Low Back PainYuanpei University of Med...
NCT07574021
The Experience of Short Video Addiction Among College StudentsSun Yat-sen UniversityNot Yet Recruiting
NCT07574021Not Yet Recruiting
—
The Experience of Short Video Addiction Among College StudentsSun Yat-sen University
NCT07572812
A Phase I Clinical Trial of UX-GIP001 in the Treatment of Drug-Resistant Unilateral Mesial Temporal Lobe EpilepsyBeijing Tiantan HospitalNot Yet RecruitingPhase 1
NCT07572812Not Yet Recruiting
Phase 1
A Phase I Clinical Trial of UX-GIP001 in the Treatment of Drug-Resistant Unilate...Beijing Tiantan Hospital
Result Breakdown
Not yet recruiting13 (65%)
Recruiting4 (20%)
Completed2 (10%)
Enrolling by invitation1 (5%)
not_applicable8 (40%)
Phase 26 (30%)
Phase 13 (15%)
Not Specified3 (15%)